Khan AP - Search Results

1

A novel kinase inhibitor of FADD phosphorylation chemosensitizes through the inhibition of NF-κB.

Schinske KA, Nyati S, Khan AP, Williams TM, Johnson TD, Ross BD, Tomás RP, Rehemtulla A. Schinske KA, et al. Among authors: khan ap. Mol Cancer Ther. 2011 Oct;10(10):1807-17. doi: 10.1158/1535-7163.MCT-11-0362. Epub 2011 Aug 22. Mol Cancer Ther. 2011. PMID: 21859840 Free PMC article.

2

High-throughput molecular imaging for the identification of FADD kinase inhibitors.

Khan AP, Schinske KA, Nyati S, Bhojani MS, Ross BD, Rehemtulla A. Khan AP, et al. J Biomol Screen. 2010 Oct;15(9):1063-70. doi: 10.1177/1087057110380570. Epub 2010 Sep 20. J Biomol Screen. 2010. PMID: 20855560 Free PMC article.

3

Molecular imaging of epidermal growth factor receptor kinase activity.

Khan AP, Contessa JN, Nyati MK, Ross BD, Rehemtulla A. Khan AP, et al. Anal Biochem. 2011 Oct 1;417(1):57-64. doi: 10.1016/j.ab.2011.05.040. Epub 2011 May 30. Anal Biochem. 2011. PMID: 21693098 Free PMC article.

4

Imaging of proteolytic activity using a conditional cell surface receptor.

Bhojani MS, Hamstra DA, Chang DC, Coppola JM, Khan AP, Reddy GR, Ross BD, Rehemtulla A. Bhojani MS, et al. Among authors: khan ap. Mol Imaging. 2006 Apr-Jun;5(2):129-37. Mol Imaging. 2006. PMID: 16954027

5

Noninvasive molecular imaging sheds light on the synergy between 5-fluorouracil and TRAIL/Apo2L for cancer therapy.

Lee KC, Hamstra DA, Bhojani MS, Khan AP, Ross BD, Rehemtulla A. Lee KC, et al. Among authors: khan ap. Clin Cancer Res. 2007 Mar 15;13(6):1839-46. doi: 10.1158/1078-0432.CCR-06-1657. Clin Cancer Res. 2007. PMID: 17363540

6

Molecular imaging of Akt kinase activity.

Zhang L, Lee KC, Bhojani MS, Khan AP, Shilman A, Holland EC, Ross BD, Rehemtulla A. Zhang L, et al. Among authors: khan ap. Nat Med. 2007 Sep;13(9):1114-9. doi: 10.1038/nm1608. Epub 2007 Aug 12. Nat Med. 2007. PMID: 17694068

7

Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy.

Lee KC, Moffat BA, Schott AF, Layman R, Ellingworth S, Juliar R, Khan AP, Helvie M, Meyer CR, Chenevert TL, Rehemtulla A, Ross BD. Lee KC, et al. Among authors: khan ap. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):443-50. doi: 10.1158/1078-0432.CCR-06-1888. Clin Cancer Res. 2007. PMID: 17255264

8

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression.

Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM. Sreekumar A, et al. Among authors: khan ap. Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762. Nature. 2009. PMID: 19212411 Free PMC article.

9

Development of selected reaction monitoring-MS methodology to measure peptide biomarkers in prostate cancer.

Yocum AK, Khan AP, Zhao R, Chinnaiyan AM. Yocum AK, et al. Among authors: khan ap. Proteomics. 2010 Oct;10(19):3506-14. doi: 10.1002/pmic.201000023. Proteomics. 2010. PMID: 20821805 Free article.

10

Targeting the MLL complex in castration-resistant prostate cancer.

Malik R, Khan AP, Asangani IA, Cieślik M, Prensner JR, Wang X, Iyer MK, Jiang X, Borkin D, Escara-Wilke J, Stender R, Wu YM, Niknafs YS, Jing X, Qiao Y, Palanisamy N, Kunju LP, Krishnamurthy PM, Yocum AK, Mellacheruvu D, Nesvizhskii AI, Cao X, Dhanasekaran SM, Feng FY, Grembecka J, Cierpicki T, Chinnaiyan AM. Malik R, et al. Among authors: khan ap. Nat Med. 2015 Apr;21(4):344-52. doi: 10.1038/nm.3830. Epub 2015 Mar 30. Nat Med. 2015. PMID: 25822367 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page